X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Cadila Healthcare with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CADILA HEALTHCARE vs ADCOCK INGRAM (S. Africa) - Comparison Results

CADILA HEALTHCARE    Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 CADILA HEALTHCARE   ADCOCK INGRAM
EQUITY SHARE DATA
    CADILA HEALTHCARE
Mar-18
ADCOCK INGRAM
Jun-14
CADILA HEALTHCARE/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs558344-   
Low Rs362248-   
Sales per share (Unadj.) Rs116.3102.2-  
Earnings per share (Unadj.) Rs17.9-25.8-  
Cash flow per share (Unadj.) Rs23.1-21.3-  
Dividends per share (Unadj.) Rs3.500-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs85.480.2-  
Shares outstanding (eoy) m1,023.74168.78-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.02.9 136.6%   
Avg P/E ratio x25.7-11.5 -224.1%  
P/CF ratio (eoy) x19.9-13.9 -143.4%  
Price / Book Value ratio x5.43.7 146.0%  
Dividend payout %19.60-   
Avg Mkt Cap Rs m470,66449,921 942.8%   
No. of employees `00011.84.3 275.3%   
Total wages/salary Rs m18,5453,133 591.9%   
Avg. sales/employee Rs Th10,072.74,019.0 250.6%   
Avg. wages/employee Rs Th1,569.1729.8 215.0%   
Avg. net profit/employee Rs Th1,547.7-1,012.7 -152.8%   
INCOME DATA
Net Sales Rs m119,04917,254 690.0%  
Other income Rs m1,132121 936.9%   
Total revenues Rs m120,18117,374 691.7%   
Gross profit Rs m28,475-2,990 -952.4%  
Depreciation Rs m5,388745 723.6%   
Interest Rs m911467 194.9%   
Profit before tax Rs m23,308-4,081 -571.1%   
Minority Interest Rs m628-11 -5,520.4%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,644255 2,213.2%   
Profit after tax Rs m18,292-4,348 -420.7%  
Gross profit margin %23.9-17.3 -138.0%  
Effective tax rate %24.2-6.2 -387.5%   
Net profit margin %15.4-25.2 -61.0%  
BALANCE SHEET DATA
Current assets Rs m82,00512,637 648.9%   
Current liabilities Rs m60,7207,110 854.0%   
Net working cap to sales %17.932.0 55.8%  
Current ratio x1.41.8 76.0%  
Inventory Days Days73111 65.9%  
Debtors Days Days98124 79.3%  
Net fixed assets Rs m83,7037,366 1,136.3%   
Share capital Rs m1,02480 1,278.3%   
"Free" reserves Rs m86,4210-   
Net worth Rs m87,44513,542 645.7%   
Long term debt Rs m25,5514,759 536.9%   
Total assets Rs m180,65325,582 706.2%  
Interest coverage x26.6-7.7 -343.8%   
Debt to equity ratio x0.30.4 83.1%  
Sales to assets ratio x0.70.7 97.7%   
Return on assets %10.6-15.2 -70.1%  
Return on equity %20.9-32.1 -65.2%  
Return on capital %22.0-19.8 -111.0%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m31,4410-   
CASH FLOW
From Operations Rs m9,1931,473 624.2%  
From Investments Rs m-9,737-452 2,153.3%  
From Financial Activity Rs m5154,319 11.9%  
Net Cashflow Rs m-295,340 -0.5%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.74 Rs / ZAR

Compare CADILA HEALTHCARE With: ACTAVIS (US)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare CADILA HEALTHCARE With: SANOFI INDIA  DISHMAN PHARMA  DR. DATSONS LABS  FULFORD INDIA  PIRAMAL ENTERPRISES  



Today's Market

Indian Indices Continue Momentum; Sensex Ends 268 Points Higher(Closing)

After opening the day marginally higher, Indian share markets continued their momentum and ended their day on a positive note.

Related Views On News

CADILA HEALTHCARE Announces Quarterly Results (3QFY19); Net Profit Down 3.7% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (down 3.7% YoY). Sales on the other hand came in at Rs 36 bn (up 9.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (2QFY19); Net Profit Down 18.6% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, CADILA HEALTHCARE has posted a net profit of Rs 4 bn (down 18.6% YoY). Sales on the other hand came in at Rs 30 bn (down 8.4% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE 2017-18 Annual Report Analysis (Annual Result Update)

Aug 16, 2018 | Updated on Aug 16, 2018

Here's an analysis of the annual report of CADILA HEALTHCARE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of CADILA HEALTHCARE. Also includes updates on the valuation of CADILA HEALTHCARE.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Are You Ready for the Big Nifty Move in the March Expiry?(Profit Hunter)

Mar 8, 2019

History suggests the Nifty could make a big move in March. Are you prepared to benefit from this opportunity?

Smallcaps Are Rallying and You Need to Make the Most of It Now(Profit Hunter)

Mar 7, 2019

Did you just miss the smallcap rally? Or is there still time to catch up? Read on for answers and more...

The One Sector to Bet on Today as India Grows into a 10 Trillion Dollar Economy(The 5 Minute Wrapup)

Mar 7, 2019

India's defence sector is suddenly under the spotlight. Can this sector ride along India's long-term growth story?

Is it the Right Time to Buy Mid and Small Caps Now?(The 5 Minute Wrapup)

Mar 6, 2019

Mid and Small Caps have underperformed large caps in the past year. Is the tide about to turn?

Elections Don't Matter!(The Honest Truth)

Mar 13, 2019

Ajit Dayal shows us why from the point of view of the Indian economy, elections don't matter.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

CADILA HEALTHCARE SHARE PRICE


Mar 19, 2019 (Close)

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE 5-YR ANALYSIS

COMPARE CADILA HEALTHCARE WITH

MARKET STATS